These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11483288)

  • 21. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the alpha-adrenoceptors mediating positive inotropy of rat left atria by use of selective agonists and antagonists.
    Williamson KL; Broadley KJ
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):181-98. PubMed ID: 2883945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Labedipinedilol-C: a third-generation dihydropyridine-type calcium channel antagonist displaying K+ channel opening, NO-dependent and adrenergic antagonist activities.
    Yeh JL; Liou SF; Liang JC; Lee CH; Chiu CC; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):130-40. PubMed ID: 16044023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new beta-adrenoceptor blocking agent derived from dehydrozingerone.
    Wu BN; Yang CR; Yang JM; Chen IJ
    Gen Pharmacol; 1994 Jul; 25(4):651-9. PubMed ID: 7958725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
    Riva E; Mennini T; Latini R
    Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological activity of (-)-discretamine, a novel vascular alpha-adrenoceptor and 5-hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens.
    Ko FN; Yu SM; Su MJ; Wu YC; Teng CM
    Br J Pharmacol; 1993 Oct; 110(2):882-8. PubMed ID: 7902181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unique xanthine derivative KMCP-98 with activation of adenosine receptor subtypes.
    Shen KP; Lin RJ; Lin CY; Chiang LC; Lai WT; Cheng CJ; Chen IJ; Wu BN
    Gen Pharmacol; 2000 Jul; 35(1):47-57. PubMed ID: 11679205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol.
    Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
    Pharmacology; 1989; 39(5):327-36. PubMed ID: 2575762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y; Sakuma I; Nakao Y; Kanno M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
    Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
    Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative assessment of beta-adrenoceptor blocking agents as simple competitive antagonists in isolated heart muscle: similarity of inotropic and chronotropic blocking potencies against isoproterenol.
    Kaumann AJ; McInerny TK; Gilmour DP; Blinks JR
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Apr; 311(3):219-36. PubMed ID: 6104792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo and in vitro pharmacological studies of a new hypotensive compound (QF0301B) in rat: comparison with prazosin, a known alpha1-adrenoceptor antagonist.
    Orallo F; Garcia-Ferreiro T; Enguix MJ; Tristan H; Masaguer C; Ravina E; Cadavid I; Loza MI
    Vascul Pharmacol; 2003 Feb; 40(2):97-108. PubMed ID: 12646398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
    Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacological studies of celiprolol: I. Beta-blocking effect, intrinsic sympathomimetic activity, vasodilating and hypotensive effects].
    Miura A; Kimura Y; Inoue K; Matsuzaki T; Ochi S; Hamada K; Hayashi S; Tamura M; Kano S; Kimura K
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):191-200. PubMed ID: 1973398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The beta-adrenoceptor stimulant properties of OPC-2009 on guinea-pig isolated tracheal, right atrial and left atrial preparations.
    Yabuuchi Y
    Br J Pharmacol; 1977 Dec; 61(4):513-21. PubMed ID: 23191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B; Allen GT
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
    Pandhi P; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trachea relaxing effects and beta2-selectivity of SPFF, a newly developed bronchodilating agent, in guinea pigs and rabbits.
    Gan LL; Wang MW; Cheng MS; Pan L
    Biol Pharm Bull; 2003 Mar; 26(3):323-8. PubMed ID: 12612441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.